Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, University of Liège, Liège 4000, Belgium.
Int J Pharm. 2020 Nov 15;589:119812. doi: 10.1016/j.ijpharm.2020.119812. Epub 2020 Aug 31.
Poor aqueous solubility of terpenophenolic compound Cannabidiol (CBD) is a major issue in the widespread use of this promising therapeutic polyphenol. Moreover, choosing the appropriate strategy to overcome this challenge is time-consuming and based on trial-error processes. The amorphous form of CBD provided higher aqueous solubility as well as faster dissolution rate in comparison with crystalline CBD. Nevertheless, amorphous forms of CBD tend to recrystallize. The aim of this study was to use three different strategies based on the stabilization of the amorphous form. Cyclodextrins (CHαCD, HPβCD and HPγCD.), mesoporous silicas (Silsol® and Syloid® AL-1FP) and water soluble polymers (Kollidon® VA64, Kollidon® 12PF and Soluplus®) were processed by using the following techniques: freeze-drying, spray-drying, subcritical carbon dioxide impregnation or hot-melt extrusion. All the obtained formulations provided complete amorphous CBD, although the drug loading depend highly of the excipients. CBD-cyclodextrin formulations, processed by freeze-drying or spray-drying, and CBD-mesoporous silica formulations, processed by subcritical CO or by atmospheric impregnation, provided significant increase of aqueous solubility. While the use of Kollidon® 12PF did not provided significant increased solubility within 90 min, Kollidon® VA64 has been highlighted as the excipient that exhibits the highest increase of aqueous solubility of this study. Finally, all formulations, excepted CBD-ALFP formulations, showed adequate stability within at least two months.
萜酚类化合物大麻二酚(CBD)的水溶性差是广泛应用这种有前途的治疗性多酚的主要问题。此外,选择适当的策略来克服这一挑战需要时间,并且基于反复试验的过程。与结晶 CBD 相比,CBD 的无定形形式提供了更高的水溶性和更快的溶解速率。然而,CBD 的无定形形式往往会重结晶。本研究的目的是使用基于稳定无定形形式的三种不同策略。使用以下技术处理环糊精(CHαCD、HPβCD 和 HPγCD)、介孔硅(Silsol® 和 Syloid® AL-1FP)和水溶性聚合物(Kollidon® VA64、Kollidon® 12PF 和 Soluplus®):冷冻干燥、喷雾干燥、亚临界二氧化碳浸渍或热熔挤出。所有获得的制剂均提供了完整的无定形 CBD,尽管药物负载高度依赖于赋形剂。通过冷冻干燥或喷雾干燥处理的 CBD-环糊精制剂和通过亚临界 CO 或常压浸渍处理的 CBD-介孔硅制剂提供了显著增加的水溶解度。虽然 Kollidon® 12PF 的使用在 90 分钟内没有提供显著增加的溶解度,但 Kollidon® VA64 被突出为表现出本研究最高水溶解度增加的赋形剂。最后,除 CBD-ALFP 制剂外,所有制剂在至少两个月内均表现出良好的稳定性。